查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390554

骨科生物製劑市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Orthobiologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球骨科生物製品市場規模達57億美元。展望未來， IMARC Group預計到2028年市場規模將達到77億美元，2022-2028年複合年成長率（CAGR）為5.14%。

骨生物製劑是利用體內天然存在的物質（例如碳水化合物、蛋白質、細胞和糖蛋白）製成的組織衍生產品。它們有助於減輕疼痛和炎症，逆轉骨關節炎的衰弱影響，並促進軟骨再生、肌腱癒合、韌帶修復和骨形成的過程。一些常用的骨科生物療法包括幹細胞、富血小板血漿 (PRP)、自體條件血漿 (ACP) 和骨髓抽吸濃縮液 (BMAC)。其中，PRP 作為一種新穎的治療方式在全球範圍內受到關注，在各種肌肉骨骼疾病中副作用最小。這些病症包括肩袖撕裂、肩峰下撞擊、肩部骨關節炎、髕腱變性、外上髁肌腱病變和膝骨關節炎。

骨科生物製劑市場趨勢：

骨科生物製劑有助於專業和休閒運動員的運動相關損傷的快速康復。個人擴大參與體育運動是對市場產生正面影響的主要因素之一。除此之外，由於身體的退化性變化，老年人可能會出現肩袖撕裂。這與老年人口的成長相結合，推動了市場的成長。此外，久坐的生活方式、不健康的飲食模式和慢性病的流行也會增加骨關節炎的風險。此外，用於侵入性手術的幾種骨科生物製劑可以在保險範圍內報銷，這正在加強市場的成長。此外，人們越來越認知到與骨科生物療法相關的好處，例如避免關節置換等重大侵入性手術和快速恢復時間，正在促進其相對於其他外科手術的採用。除此之外，骨科手術數量的增加以及骨折固定用生物可吸收植入物的需求不斷增加，促進了骨科生物製品的使用，例如自體移植骨和同種異體移植骨以及脫礦骨基質在兒科人群中的使用。

本報告回答的關鍵問題：

  • 迄今為止，全球骨科生物製品市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球骨科生物製劑市場有何影響？
  • 主要區域市場有哪些？
  • 基於產品的市場區隔是什麼？
  • 依類型分類市場是怎麼樣的？
  • 基於應用程式的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球骨科生物製品市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球骨科生物製品市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 去礦骨基質
    • 市場走向
    • 市場預測
  • 同種異體移植物
    • 市場走向
    • 市場預測
  • 骨形態發生蛋白
    • 市場走向
    • 市場預測
  • 黏稠補充產品
    • 市場走向
    • 市場預測
  • 合成骨替代品
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按類型分類的市場細分

  • 膝蓋
    • 市場走向
    • 市場預測
  • 踝
    • 市場走向
    • 市場預測
  • 時髦的
    • 市場走向
    • 市場預測
  • 手腕和肩膀
    • 市場走向
    • 市場預測
  • 脊椎
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按應用分類的市場區隔

  • 骨關節炎和退化性關節炎
    • 市場走向
    • 市場預測
  • 脊椎融合術
    • 市場走向
    • 市場預測
  • 骨折恢復
    • 市場走向
    • 市場預測
  • 軟組織損傷
    • 市場走向
    • 市場預測
  • 顎面和牙科應用
    • 市場走向
    • 市場預測

第 9 章：最終用戶的市場區隔

  • 醫院及門診中心
    • 市場走向
    • 市場預測
  • 研究和學術機構
    • 市場走向
    • 市場預測
  • 牙科診所和設施
    • 市場走向
    • 市場預測
  • 骨科診所
    • 市場走向
    • 市場預測

第 10 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Arthrex Inc
    • Globus Medical Inc.
    • Integra LifeSciences
    • Johnson & Johnson
    • Medline Industries Inc.
    • Medtronic plc
    • NuVasive Inc
    • Orthofix Medical Inc.
    • Smith & Nephew plc
    • Stryker Corporation
    • Terumo Corporation
    • Wright Medical Group NV
    • Zimmer Biomet
Product Code: SR112023A4332

Abstract

The global orthobiologics market size reached US$ 5.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.14% during 2022-2028.

Orthobiologics are tissue-derived products made using substances that are naturally found in the body, such as carbohydrates, proteins, cells, and glycoproteins. They assist in reducing pain and inflammation, reversing debilitating effects of osteoarthritis, and facilitating the process of cartilage regeneration, tendon healing, ligament repairing, and bone formation. Some of the commonly utilized orthobiologic therapies are stem cells, platelet-rich plasma (PRP), autologous conditioned plasma (ACP), and bone marrow aspirate concentrate (BMAC). Amongst these, PRP is gaining traction across the globe as novel treatment modalities with minimal side effects in diverse musculoskeletal conditions. These conditions include rotator cuff tears, sub-acromial impingement, shoulder osteoarthritis, patellar tendinosis, lateral epicondylar tendinopathy, and knee osteoarthritis.

Orthobiologics Market Trends:

Orthobiologics aid in the quick recovery of sports-related injuries among professional and recreational athletes. The increasing participation of individuals in sports and physical activities represents one of the major factors influencing the market positively. Apart from this, rotator cuff tears can appear among older people due to degenerative changes in the body. This, in confluence with the growing geriatric population, is impelling the market growth. Moreover, the risk of developing osteoarthritis can be increased due to sedentary lifestyles, unhealthy dietary patterns, and the prevalence of chronic diseases. In addition, several orthobiologics utilized for invasive surgeries can be reimbursed under insurance coverage, which is strengthening the market growth. Furthermore, the growing awareness about the benefits associated with orthobiologic therapies, such as avoiding major invasive surgery like joint replacement and fast recovery time, is promoting their adoption over other surgical procedures. Besides this, the increasing number of orthopedic surgeries and the escalating demand for bioabsorbable implants for fracture fixation is contributing to the use of orthobiologics, such as autograft and allograft bone, and demineralized bone matrix, among the pediatric population.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global orthobiologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type, application and end user.

Breakup by Product:

Demineralized Bone Matrix

Allograft

Bone Morphogenetic Protein

Viscosupplementation Products

Synthetic Bone Substitutes

Others

Breakup by Type:

Knee

Ankle

Hip

Wrist and Shoulder

Spine

Others

Breakup by Application:

Osteoarthritis and Degenerative Arthritis

Spinal Fusion

Fracture Recovery

Soft Tissue Injuries

Maxillofacial and Dental Applications

Breakup by End User:

Hospitals and Ambulatory Centers

Research and Academic Institutes

Dental Clinics and Facilities

Orthopedic Clinics

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc, Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries Inc., Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, Wright Medical Group N.V. and Zimmer Biomet.

Key Questions Answered in This Report:

  • How has the global orthobiologics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global orthobiologics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global orthobiologics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Orthobiologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Demineralized Bone Matrix
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Allograft
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bone Morphogenetic Protein
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Viscosupplementation Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Synthetic Bone Substitutes
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Knee
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ankle
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hip
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Wrist and Shoulder
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Spine
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Osteoarthritis and Degenerative Arthritis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Spinal Fusion
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Fracture Recovery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Soft Tissue Injuries
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Maxillofacial and Dental Applications
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Ambulatory Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research and Academic Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Dental Clinics and Facilities
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Orthopedic Clinics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Arthrex Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Globus Medical Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Integra LifeSciences
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Medline Industries Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Medtronic plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 NuVasive Inc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Orthofix Medical Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Smith & Nephew plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Stryker Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Terumo Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Wright Medical Group N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis
    • 15.3.13 Zimmer Biomet
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Orthobiologics Market: Major Drivers and Challenges
  • Figure 2: Global: Orthobiologics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Orthobiologics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Orthobiologics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Orthobiologics Market: Breakup by Type (in %), 2022
  • Figure 6: Global: Orthobiologics Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Orthobiologics Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Orthobiologics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Orthobiologics (Demineralized Bone Matrix) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Orthobiologics (Demineralized Bone Matrix) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Orthobiologics (Allograft) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Orthobiologics (Allograft) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Orthobiologics (Bone Morphogenetic Protein) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Orthobiologics (Bone Morphogenetic Protein) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Orthobiologics (Viscosupplementation Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Orthobiologics (Viscosupplementation Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Orthobiologics (Synthetic Bone Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Orthobiologics (Synthetic Bone Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Orthobiologics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Orthobiologics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Orthobiologics (Knee) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Orthobiologics (Knee) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Orthobiologics (Ankle) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Orthobiologics (Ankle) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Orthobiologics (Hip) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Orthobiologics (Hip) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Orthobiologics (Wrist and Shoulder) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Orthobiologics (Wrist and Shoulder) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Orthobiologics (Spine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Orthobiologics (Spine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Orthobiologics (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Orthobiologics (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Orthobiologics (Osteoarthritis and Degenerative Arthritis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Orthobiologics (Osteoarthritis and Degenerative Arthritis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Orthobiologics (Spinal Fusion) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Orthobiologics (Spinal Fusion) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Orthobiologics (Fracture Recovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Orthobiologics (Fracture Recovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Orthobiologics (Soft Tissue Injuries) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Orthobiologics (Soft Tissue Injuries) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Orthobiologics (Maxillofacial and Dental Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Orthobiologics (Maxillofacial and Dental Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Orthobiologics (Hospitals and Ambulatory Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Orthobiologics (Hospitals and Ambulatory Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Orthobiologics (Research and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Orthobiologics (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Orthobiologics (Dental Clinics and Facilities) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Orthobiologics (Dental Clinics and Facilities) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Orthobiologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Orthobiologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: North America: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: North America: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: United States: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: United States: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Canada: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Canada: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Asia-Pacific: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Asia-Pacific: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: China: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: China: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Japan: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Japan: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: India: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: India: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: South Korea: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: South Korea: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Australia: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Australia: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Indonesia: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Indonesia: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Europe: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Europe: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Germany: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Germany: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: France: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: France: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: United Kingdom: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: United Kingdom: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Italy: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Italy: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Spain: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Spain: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Russia: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Russia: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Latin America: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Latin America: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Brazil: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Brazil: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Mexico: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Mexico: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Others: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Others: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Middle East and Africa: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Middle East and Africa: Orthobiologics Market: Breakup by Country (in %), 2022
  • Figure 99: Middle East and Africa: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 100: Global: Orthobiologics Industry: SWOT Analysis
  • Figure 101: Global: Orthobiologics Industry: Value Chain Analysis
  • Figure 102: Global: Orthobiologics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Orthobiologics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Orthobiologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Orthobiologics Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 4: Global: Orthobiologics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Orthobiologics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Orthobiologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Orthobiologics Market: Competitive Structure
  • Table 8: Global: Orthobiologics Market: Key Players